Established in 2011, MicroTech Medical is located in the Hangzhou Future Sci-Tech City, which is the leading venture technology park in Hangzhou. Shortly after, the US R&D center was established in California’s Silicon Valley.
MicroTech’s management and technical teams were recruited from all over the world, with the majority of the group having post-secondary, graduate and/or post-graduate university degrees as well as extensive experience in medical technology.
MicroTech’s certifications include regulatory approvals for CE and CFDA, as well as product conformity to ISO 15197:2015 (BGMS products) and IEC 60601-2-24 (pump therapy products). In 2013, the government designated MicroTech as Lead Diabetes Research Center in Zhejiang Province.
MicroTech Medical is devoted to innovation in chronic disease management, and strives to bring to market healthcare products globally. The company’s portfolio includes therapy products such as the Equil Patch Insulin Pump and diagnostic products such as the AiDEX Continuous Glucose Monitoring System (CGMS), multiple lines of Blood Glucose Monitoring Systems (BGMS), and POCT products.
With the help this line of products, MicroTech Medical continues to allow more freedom, flexibility, and choice to those who are limited by chronic disease.
Finances Blockchain-enabled investments.
Chinese multinational technology company
Primarily focusing on investing in China related VC & PE projects.
One of Silicon Valley’s leading business networks.
An established and well-known investment institution
Aims to establish long-term relationships with outstanding companies.
BEAMSTART is a Global Community and News Portal for Entrepreneurship. We cover the latest news and bring together a global network of CEOs/founders, Investors, Business Leaders, and Professionals.
Connect with the BEAMSTART Entrepreneurship Community from the palm of your hands. Connect with CEOs/Founders, Investors, Business Leaders, and Professionals. Download below to instantly form partnerships and discover opportunities: